MONDAY, Oct. 22, 2018 -- Childhood obesity has been linked to a higher risk of type 2 diabetes and early heart disease, but new research now ties it to a sometimes crippling hip condition.
It's called slipped capital femoral epiphysis (SCFE), and it causes the hip to become deformed, occasionally so much so that the hip collapses. SCFE causes pain and may result in lifelong disability, British researchers said.
MONDAY, Oct. 22, 2018 -- Deaths and complications among pregnant women with lupus have declined in the United States over the past two decades, a new study finds.
Lupus, also called systemic lupus erythematosus (SLE), is a chronic autoimmune disease that causes inflammation in many parts of the body, including the kidneys, skin and joints, as well as the tissue lining the lungs, heart and brain.
MONDAY, Oct. 22, 2018 -- With the national shortage of primary care doctors and -- in certain areas -- specialists, and with a quarter of the population living in rural areas without easy access to care, telehealth has stepped in to help fill the gap.
In fact, millions of Americans now use it every year.
MONDAY, Oct. 22, 2018 -- The U.S. Drug and Food Administration has repeatedly warned manufacturers that many dietary supplements contain dangerous, experimental stimulants. But according to a new report, 75 percent of supplements tested still contain the compounds.
"Consumers turn to supplements for safe, natural ways to increase energy, improve workouts or lose weight," said study author Dr. Pieter Cohen, an associate professor with Harvard Medical School. "[But] what most consumers don't know is that supplements can be sold as if they give you energy, help you lose weight or just about anything, as long as the supplement does not claim to cure or treat disease."
MONDAY, Oct. 22, 2018 -- Two common antipsychotic drugs are ineffective in treating delirium in intensive care unit patients, and don't shorten the length of time spent in the ICU or the hospital, a new study finds.
Despite widespread use of haloperidol or ziprasidone, "we found, after extensive investigation with medical centers all over the country, that the patients who get these potentially dangerous drugs are not experiencing any improvements whatsoever in delirium, coma, length of stay or survival," said senior author Dr. E. Wesley Ely.